{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:42:57Z","timestamp":1761864177076},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s11239-020-02281-7","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T10:03:00Z","timestamp":1600682580000},"page":"1026-1035","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Determinants of ST-segment elevation myocardial infarction as clinical presentation of acute coronary syndrome"],"prefix":"10.1007","volume":"51","author":[{"given":"Osamu","family":"Kurihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunekazu","family":"Kakuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunenari","family":"Soeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Crea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Adriaenssens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger M.","family":"Nef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas F.","family":"Boeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Oh","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"McNulty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoichi","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ik -Kyung","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"key":"2281_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/heart.83.3.361","volume":"83","author":"MJ Davies","year":"2000","unstructured":"Davies MJ (2000) The pathophysiology of acute coronary syndromes. Heart 83:361\u2013366. https:\/\/doi.org\/10.1136\/heart.83.3.361","journal-title":"Heart"},{"key":"2281_CR2","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","volume":"114","author":"JF Bentzon","year":"2014","unstructured":"Bentzon JF, Otsuka F, Virmani R, Falk E (2014) Mechanisms of plaque formation and rupture. Circ Res 114:1852\u20131866. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.302721","journal-title":"Circ Res"},{"key":"2281_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ, Group ESCSD (2020) 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 41:407\u2013477. https:\/\/doi.org\/10.1093\/eurheartj\/ehz425","journal-title":"Eur Heart J"},{"key":"2281_CR4","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.jacc.2010.06.028","volume":"56","author":"JD Rich","year":"2010","unstructured":"Rich JD, Cannon CP, Murphy SA, Qin J, Giugliano RP, Braunwald E (2010) Prior aspirin use and outcomes in acute coronary syndromes. J Am Coll Cardiol 56:1376\u20131385. https:\/\/doi.org\/10.1016\/j.jacc.2010.06.028","journal-title":"J Am Coll Cardiol"},{"key":"2281_CR5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-140-11-200406010-00006","volume":"140","author":"FA Spencer","year":"2004","unstructured":"Spencer FA, Allegrone J, Goldberg RJ, Gore JM, Fox KA, Granger CB, Mehta RH, Brieger D, Investigators G (2004) Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med 140:857\u2013866. https:\/\/doi.org\/10.7326\/0003-4819-140-11-200406010-00006","journal-title":"Ann Intern Med"},{"key":"2281_CR6","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.jacc.2013.05.071","volume":"62","author":"H Jia","year":"2013","unstructured":"Jia H, Abtahian F, Aguirre AD, Lee S, Chia S, Lowe H, Kato K, Yonetsu T, Vergallo R, Hu S, Tian J, Lee H, Park SJ, Jang YS, Raffel OC, Mizuno K, Uemura S, Itoh T, Kakuta T, Choi SY, Dauerman HL, Prasad A, Toma C, McNulty I, Zhang S, Yu B, Fuster V, Narula J, Virmani R, Jang IK (2013) In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol 62:1748\u20131758. https:\/\/doi.org\/10.1016\/j.jacc.2013.05.071","journal-title":"J Am Coll Cardiol"},{"key":"2281_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/00041433-200410000-00012","volume":"15","author":"FD Kolodgie","year":"2004","unstructured":"Kolodgie FD, Burke AP, Wight TN, Virmani R (2004) The accumulation of specific types of proteoglycans in eroded plaques: a role in coronary thrombosis in the absence of rupture. Curr Opin Lipidol 15:575\u2013582. https:\/\/doi.org\/10.1097\/00041433-200410000-00012","journal-title":"Curr Opin Lipidol"},{"key":"2281_CR8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/hrt.2004.034058","volume":"91","author":"Y Sato","year":"2005","unstructured":"Sato Y, Hatakeyama K, Yamashita A, Marutsuka K, Sumiyoshi A, Asada Y (2005) Proportion of fibrin and platelets differs in thrombi on ruptured and eroded coronary atherosclerotic plaques in humans. Heart 91:526\u2013530. https:\/\/doi.org\/10.1136\/hrt.2004.034058","journal-title":"Heart"},{"key":"2281_CR9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(17)31632-X","volume":"390","author":"P Damman","year":"2017","unstructured":"Damman P, de Winter RJ (2017) Timing of revascularisation for acute coronary syndrome. Lancet 390:717\u2013718. https:\/\/doi.org\/10.1016\/S0140-6736(17)31632-X","journal-title":"Lancet"},{"key":"2281_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jcin.2010.09.022","volume":"4","author":"Y Ino","year":"2011","unstructured":"Ino Y, Kubo T, Tanaka A, Kuroi A, Tsujioka H, Ikejima H, Okouchi K, Kashiwagi M, Takarada S, Kitabata H, Tanimoto T, Komukai K, Ishibashi K, Kimura K, Hirata K, Mizukoshi M, Imanishi T, Akasaka T (2011) Difference of culprit lesion morphologies between st-segment elevation myocardial infarction and non-st-segment elevation acute coronary syndrome: an optical coherence tomography study. JACC Cardiovasc Interv 4:76\u201382. https:\/\/doi.org\/10.1016\/j.jcin.2010.09.022","journal-title":"JACC Cardiovasc Interv"},{"key":"2281_CR11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1253\/circj.CJ-16-0957","volume":"81","author":"T Yonetsu","year":"2017","unstructured":"Yonetsu T, Lee T, Murai T, Kanno Y, Hamaya R, Ichijo S, Niida T, Hada M, Araki M, Matsuda J, Usui E, Hoshino M, Kanaji Y, Kakuta T (2017) Association between prior aspirin use and morphological features of culprit lesions at first presentation of acute coronary syndrome assessed by optical coherence tomography. Circ J 81:511\u2013519. https:\/\/doi.org\/10.1253\/circj.CJ-16-0957","journal-title":"Circ J"},{"key":"2281_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/ehjci\/jeu228","volume":"16","author":"N Amabile","year":"2015","unstructured":"Amabile N, Hammas S, Fradi S, Souteyrand G, Veugeois A, Belle L, Motreff P, Caussin C (2015) Intra-coronary thrombus evolution during acute coronary syndrome: regression assessment by serial optical coherence tomography analyses. Eur Heart J Cardiovasc Imaging 16:433\u2013440. https:\/\/doi.org\/10.1093\/ehjci\/jeu228","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2281_CR13","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/j.jacc.2010.01.034","volume":"55","author":"JA Barrabes","year":"2010","unstructured":"Barrabes JA, Galian L (2010) Endogenous thrombolysis: a hidden player in acute coronary syndromes? J Am Coll Cardiol 55:2116\u20132117. https:\/\/doi.org\/10.1016\/j.jacc.2010.01.034","journal-title":"J Am Coll Cardiol"},{"key":"2281_CR14","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","volume":"373","author":"C Baigent","year":"2009","unstructured":"Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373:1849\u20131860. https:\/\/doi.org\/10.1016\/S0140-6736(09)60503-1","journal-title":"Lancet"},{"key":"2281_CR15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1056\/NEJMoa020496","volume":"347","author":"M Hurlen","year":"2002","unstructured":"Hurlen M, Abdelnoor M, Smith P, Erikssen J, Arnesen H (2002) Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 347:969\u2013974. https:\/\/doi.org\/10.1056\/NEJMoa020496","journal-title":"N Engl J Med"},{"key":"2281_CR16","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/eurheartj\/ehw381","volume":"38","author":"H Jia","year":"2017","unstructured":"Jia H, Dai J, Hou J, Xing L, Ma L, Liu H, Xu M, Yao Y, Hu S, Yamamoto E, Lee H, Zhang S, Yu B, Jang IK (2017) Effective anti-thrombotic therapy without stenting: Intravascular optical coherence tomography-based management in plaque erosion (the erosion study). Eur Heart J 38:792\u2013800. https:\/\/doi.org\/10.1093\/eurheartj\/ehw381","journal-title":"Eur Heart J"},{"key":"2281_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/MCA.0000000000000614","volume":"29","author":"T Sugiyama","year":"2018","unstructured":"Sugiyama T, Xing L, Yamamoto E, Fracassi F, Lee H, Yu B, Jang IK (2018) Thrombus resolution with tirofiban in the conservative management of patients presenting with plaque erosion. Coron Artery Dis 29:301\u2013308. https:\/\/doi.org\/10.1097\/MCA.0000000000000614","journal-title":"Coron Artery Dis"},{"key":"2281_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/hc2901.093188","volume":"104","author":"M Schartl","year":"2001","unstructured":"Schartl M, Bocksch W, Koschyk DH, Voelker W, Karsch KR, Kreuzer J, Hausmann D, Beckmann S, Gross M (2001) Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 104:387\u2013392. https:\/\/doi.org\/10.1161\/hc2901.093188","journal-title":"Circulation"},{"key":"2281_CR19","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1016\/j.jacc.2014.08.045","volume":"64","author":"K Komukai","year":"2014","unstructured":"Komukai K, Kubo T, Kitabata H, Matsuo Y, Ozaki Y, Takarada S, Okumoto Y, Shiono Y, Orii M, Shimamura K, Ueno S, Yamano T, Tanimoto T, Ino Y, Yamaguchi T, Kumiko H, Tanaka A, Imanishi T, Akagi H, Akasaka T (2014) Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: The easy-fit study. J Am Coll Cardiol 64:2207\u20132217. https:\/\/doi.org\/10.1016\/j.jacc.2014.08.045","journal-title":"J Am Coll Cardiol"},{"key":"2281_CR20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/heart.84.5.483","volume":"84","author":"C von Birgelen","year":"2000","unstructured":"von Birgelen C, Klinkhart W, Mintz GS, Wieneke H, Baumgart D, Haude M, Bartel T, Sack S, Ge J, Erbel R (2000) Size of emptied plaque cavity following spontaneous rupture is related to coronary dimensions, not to the degree of lumen narrowing. A study with intravascular ultrasound in vivo. Heart 84:483\u2013488. https:\/\/doi.org\/10.1136\/heart.84.5.483","journal-title":"Heart"},{"key":"2281_CR21","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1093\/eurheartj\/ehn286","volume":"29","author":"OC Raffel","year":"2008","unstructured":"Raffel OC, Merchant FM, Tearney GJ, Chia S, Gauthier DD, Pomerantsev E, Mizuno K, Bouma BE, Jang IK (2008) In vivo association between positive coronary artery remodelling and coronary plaque characteristics assessed by intravascular optical coherence tomography. Eur Heart J 29:1721\u20131728. https:\/\/doi.org\/10.1093\/eurheartj\/ehn286","journal-title":"Eur Heart J"},{"key":"2281_CR22","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/ehjci\/jew208","volume":"18","author":"G Scalone","year":"2017","unstructured":"Scalone G, Niccoli G, Refaat H, Vergallo R, Porto I, Leone AM, Burzotta F, D'Amario D, Liuzzo G, Fracassi F, Trani C, Crea F (2017) Not all plaque ruptures are born equal: an optical coherence tomography study. Eur Heart J Cardiovasc Imaging 18:1271\u20131277. https:\/\/doi.org\/10.1093\/ehjci\/jew208","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2281_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1161\/CIRCRESAHA.118.311098","volume":"124","author":"P Libby","year":"2019","unstructured":"Libby P, Pasterkamp G, Crea F, Jang IK (2019) Reassessing the mechanisms of acute coronary syndromes. Circ Res 124:150\u2013160. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.311098","journal-title":"Circ Res"},{"key":"2281_CR24","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1161\/CIRCULATIONAHA.110.955302","volume":"122","author":"G Ferrante","year":"2010","unstructured":"Ferrante G, Nakano M, Prati F, Niccoli G, Mallus MT, Ramazzotti V, Montone RA, Kolodgie FD, Virmani R, Crea F (2010) High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study. Circulation 122:2505\u20132513. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.955302","journal-title":"Circulation"},{"key":"2281_CR25","doi-asserted-by":"publisher","first-page":"e0116621","DOI":"10.1371\/journal.pone.0116621","volume":"10","author":"CW Kessinger","year":"2015","unstructured":"Kessinger CW, Kim JW, Henke PK, Thompson B, McCarthy JR, Hara T, Sillesen M, Margey RJ, Libby P, Weissleder R, Lin CP, Jaffer FA (2015) Statins improve the resolution of established murine venous thrombosis: Reductions in thrombus burden and vein wall scarring. PLoS ONE 10:e0116621. https:\/\/doi.org\/10.1371\/journal.pone.0116621","journal-title":"PLoS ONE"},{"key":"2281_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/1074248417753677","volume":"23","author":"F Mayyas","year":"2018","unstructured":"Mayyas F, Baydoun D, Ibdah R, Ibrahim K (2018) Atorvastatin reduces plasma inflammatory and oxidant biomarkers in patients with risk of atherosclerotic cardiovascular disease. J Cardiovasc Pharmacol Ther 23:216\u2013225. https:\/\/doi.org\/10.1177\/1074248417753677","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"2281_CR27","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1253\/circj.CJ-19-0133","volume":"83","author":"K Kimura","year":"2019","unstructured":"Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K, Sakamoto T, Tsujita K, Hagiwara N, Miyazaki S, Ako J, Arai H, Ishii H, Origuchi H, Shimizu W, Takemura H, Tahara Y, Morino Y, Iino K, Itoh T, Iwanaga Y, Uchida K, Endo H, Kongoji K, Sakamoto K, Shiomi H, Shimohama T, Suzuki A, Takahashi J, Takeuchi I, Tanaka A, Tamura T, Nakashima T, Noguchi T, Fukamachi D, Mizuno T, Yamaguchi J, Yodogawa K, Kosuge M, Kohsaka S, Yoshino H, Yasuda S, Shimokawa H, Hirayama A, Akasaka T, Haze K, Ogawa H, Tsutsui H, Yamazaki T (2019) JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome. Circ J 83:1085\u20131196. https:\/\/doi.org\/10.1253\/circj.CJ-19-0133","journal-title":"Circ J"},{"key":"2281_CR28","doi-asserted-by":"publisher","first-page":"e012322","DOI":"10.1161\/JAHA.119.012322","volume":"8","author":"E Yamamoto","year":"2019","unstructured":"Yamamoto E, Yonetsu T, Kakuta T, Soeda T, Saito Y, Yan BP, Kurihara O, Takano M, Niccoli G, Higuma T, Kimura S, Minami Y, Ako J, Adriaenssens T, Boeder NF, Nef HM, Fracassi F, Sugiyama T, Lee H, Crea F, Kimura T, Fujimoto JG, Fuster V, Jang IK (2019) Clinical and laboratory predictors for plaque erosion in patients with acute coronary syndromes. J Am Heart Assoc 8:e012322. https:\/\/doi.org\/10.1161\/JAHA.119.012322","journal-title":"J Am Heart Assoc"},{"key":"2281_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/jama.2018.20578","volume":"321","author":"SL Zheng","year":"2019","unstructured":"Zheng SL, Roddick AJ (2019) Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis. JAMA 321:277\u2013287. https:\/\/doi.org\/10.1001\/jama.2018.20578","journal-title":"JAMA"},{"key":"2281_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s1567-5688(03)90002-x","volume":"4","author":"TC Wascher","year":"2003","unstructured":"Wascher TC (2003) Long-term statin safety and efficacy in secondary prevention: can combination therapy improve outcomes? Atheroscler Suppl 4:11\u201316. https:\/\/doi.org\/10.1016\/s1567-5688(03)90002-x","journal-title":"Atheroscler Suppl"},{"key":"2281_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1001\/archinte.164.1.40","volume":"164","author":"CH Hennekens","year":"2004","unstructured":"Hennekens CH, Sacks FM, Tonkin A, Jukema JW, Byington RP, Pitt B, Berry DA, Berry SM, Ford NF, Walker AJ, Natarajan K, Sheng-Lin C, Fiedorek FT, Belder R (2004) Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses. Arch Intern Med 164:40\u201344. https:\/\/doi.org\/10.1001\/archinte.164.1.40","journal-title":"Arch Intern Med"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02281-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-020-02281-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02281-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T01:49:41Z","timestamp":1632188981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-020-02281-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["2281"],"URL":"https:\/\/doi.org\/10.1007\/s11239-020-02281-7","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"11 September 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Jang has received educational grants from Abbott Vascular and a consulting fee from Svelte Medical Systems. They had no role in the design or conduct of this research. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}